Connect Biopharma Holdings Ltd (CNTB) stock
CNTBNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.58−0.06 (-9.98%)
Close on Nov 17, 2026Market cap $36.45MP/E –Yield –
Connect Biopharma profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Connect Biopharma's profit margin for the twelve months ending Jun 30, 2026 was -2336.3%. For fiscal 2025 it was -86687.5%, against -60.0% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -86687.5% | −86627.5 |
| FY2024 | Dec 31, 2024 | -60.0% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -624.4% | +651.5 |
| Q1 FY2026 | Mar 31, 2026 | -11478.1% | −10421.8 |
| Q3 FY2025 | Sep 30, 2025 | -107500.0% | −107561.6 |
| Q2 FY2025 | Jun 30, 2025 | -26872.9% | – |
| Q4 FY2024 | Dec 31, 2024 | -1275.9% | – |
| Q3 FY2024 | Sep 30, 2024 | -1056.3% | – |
| Q2 FY2024 | Jun 30, 2024 | 61.6% | – |
See a number that looks wrong?